I'm not talking about straight up production though. DeRosa's value was that he could be productive and fill numerous positions on the field (obviously not at once . . . ). That would be even more valuable this year with Bradley being added. We've already seen the defensive hit we took when Aramis went down and Fontenot had to play there (though he seems to have improved somewhat). Already Miles and Freel are getting at bats that we didn't know they'd be getting (with Aramis out til August) and DeRosa could have filled that void. DeRo could have gotten plenty of at-bats in the supersub/first off the bench role. He probably wouldn't have started every day, but he would have gotten plenty of starts between having to rest Bradley and Ramirez. And as for Tim's argument, yes, sometimes it is best to sell high, and DeRo's value wasn't going to get any higher. If you pull the trigger on that trade, Hendry did it at the right time. However, he didn't get anything close to what DeRo was worth. And also, sometimes the best trade is the one you don't make. We're really missing him now when we really could have used him. It's not like it was a huge stretch to foresee Bradley or Aram missing significant time with an injury. Exactly. When choosing to sell high, you must be certain that what you're getting in return is more valuable than the player you are shipping out. DeRosa's value is just too high for a pretty good reliever and two high risk/high reward starters to make up for. The only real exception to this is if you feel the player's production is going to completely collapse. I saw no evidence in the offseason that DeRosa would do that. He's back up to a .751 OPS, by the way. And he had a .242 BABIP in April. I think he'll come around.